House Energy and Commerce Committee Chairman Frank Pallone Jr., D-NJ, today re-introduced the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) with other Democratic committee leaders.

The legislation would authorize the Health and Human Services Secretary to negotiate Medicare prescription drug prices; cap beneficiary out-of-pocket spending for prescription drugs at $2,000 per year; require drug makers that increase prices faster than inflation to pay a rebate to the federal government; and invest anticipated savings in federal programs to develop treatments and address the opioid crisis.

Yesterday, House Republican committee leaders introduced the Lower Cost, More Cures Act (H.R. 19), also intended to lower drug costs. View a summary here.

In addition, Sens. Dick Durbin, D-Ill., and Rob Portman, R-Ohio, introduced AHA-supported legislation that would reduce spending on discarded medications that are the result of excessively large, single-use drug vials. The Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act would enable Medicare to recoup money from drug companies that are paid for wasted medications, and provide savings to seniors enrolled in Medicare.

 

Related News Articles

Headline
The Workgroup for Electronic Data Interchange advisory group yesterday urged Health and Human Services Secretary Xavier Becerra to work closely with standards…
Perspective
After Election Day, lawmakers will return to Washington to consider many important issues, including funding the government, the annual must-pass defense bill…
Headline
At an AHA virtual policy briefing today for congressional staff, hospital and health system leaders urged Congress to prioritize actions to address the…
Headline
As Congress begins to focus on its year-end agenda, AHA today urged lawmakers to prioritize certain actions to help hospitals and health systems address rising…
Headline
Price increases for over 1,200 drugs exceeded inflation between July 2021 and July 2022, including many drugs used to treat cancer and other chronic conditions…
Headline
The Centers for Medicare & Medicaid Services yesterday released premium and cost-sharing information for Medicare Advantage and Part D prescription drug…